These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 5999012)

  • 41. [Effect of single ingestion of a daily dose of cycloserine on the bioelectric activity of the cerebral cortex in children].
    Kirina EA; Adamova EA
    Probl Tuberk; 1970; 48(4):44-8. PubMed ID: 5471128
    [No Abstract]   [Full Text] [Related]  

  • 42. [Use of 2d series tuberculostatic agents in the chemotherapy of pulmonary tuberculosis].
    Tikhonov VA
    Probl Tuberk; 1969; 47(3):15-9. PubMed ID: 5354628
    [No Abstract]   [Full Text] [Related]  

  • 43. [Psychiatric and neurological symptoms caused by cycloserine poisoning].
    Nakamura K
    Seishin Shinkeigaku Zasshi; 1968 Jun; 70(6):503-21. PubMed ID: 5749977
    [No Abstract]   [Full Text] [Related]  

  • 44. [Therapy with PAS, rifamycin and ethionamide administered intravenously and its effects on glucide metabolism in diabetics affected by pulmonary tuberculosis].
    Filla E; Comenale D
    Minerva Med; 1965 Dec; 56(103):4570-3. PubMed ID: 5858896
    [No Abstract]   [Full Text] [Related]  

  • 45. [Blood level of ethionamide and prothionamide in patients with pulmonary tuberculosis].
    Tikhonov VA; Kanevskaia SS
    Probl Tuberk; 1971; 49(8):58-60. PubMed ID: 5152635
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical activity of cycloserine in the treatment of pulmonary tuberculosis.
    Jimenez M
    Scand J Respir Dis Suppl; 1970; 71():172-3. PubMed ID: 5271980
    [No Abstract]   [Full Text] [Related]  

  • 47. [On the present status of chemotherapy of lung tuberculosis, especially in ambulatory use].
    Rink H
    Z Tuberk Erkr Thoraxorg; 1967 Apr; 126(1):1-12. PubMed ID: 5631774
    [No Abstract]   [Full Text] [Related]  

  • 48. Results of treatment of pulmonary tuberculosis with cycloserine in association with other drugs.
    Bethlem N
    Scand J Respir Dis Suppl; 1970; 71():244-9. PubMed ID: 5271994
    [No Abstract]   [Full Text] [Related]  

  • 49. [Chemotherapy effectiveness in destructive pulmonary tuberculosis in the middle-aged and elderly using different methods of administering the preparations].
    Abrarov BA; Tursunov FI; Leĭbzon IuN; Slobodskoĭ SA; Arifov SA
    Probl Tuberk; 1982 Mar; (3):34-7. PubMed ID: 7088920
    [No Abstract]   [Full Text] [Related]  

  • 50. [The use of ethionamide in the treatment of primary infection in children].
    Guimard P; Gouyon C
    Rev Tuberc Pneumol (Paris); 1966 Dec; 30(12):1250-5. PubMed ID: 5299637
    [No Abstract]   [Full Text] [Related]  

  • 51. [Intravenous ethionamide drips in the treatment of pulmonary tuberculosis].
    Czajka-Kropaczek L; Ostrowska A
    Gruzlica; 1969 Dec; 37(12):1071-6. PubMed ID: 5368633
    [No Abstract]   [Full Text] [Related]  

  • 52. [Late results of treatment of chronic, cavernous pulmonary tuberculosis with reserve drugs].
    Zierski M; Zachara A
    Gruzlica; 1968; 37(1):31-8. PubMed ID: 5720035
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical effectiveness of ethionamide in chronic forms of pulmonary tuberculosis in middle-aged and elderly persons].
    Kurochkin SIa
    Vrach Delo; 1971 Jun; (6):60-1. PubMed ID: 5093596
    [No Abstract]   [Full Text] [Related]  

  • 54. [Study of concentration of ethionamide and prothionamide in the blood of patients with pulmonary tuberculosis by polarographic method].
    Tikhonov VA; Grigaliunas AP; Guzeeva SA
    Probl Tuberk; 1976 May; (5):75-8. PubMed ID: 951413
    [No Abstract]   [Full Text] [Related]  

  • 55. [Use of a soluble preparation of ethylisothiamide in venous perfusion and topical instillation].
    Sala L
    Friuli Med; 1965; 20(1):85-95. PubMed ID: 5829207
    [No Abstract]   [Full Text] [Related]  

  • 56. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN; Barrera L
    Medicina (B Aires); 2007; 67(3):231-7. PubMed ID: 17628909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Morphazinamide--clinical tolerance and side effects].
    Lachowicz D; Siekierzyńska A; Styszewska H
    Gruzlica; 1967 May; 35(5):453-63. PubMed ID: 6056260
    [No Abstract]   [Full Text] [Related]  

  • 58. Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.
    Park SK; Lee WC; Lee DH; Mitnick CD; Han L; Seung KJ
    Int J Tuberc Lung Dis; 2004 Mar; 8(3):361-8. PubMed ID: 15139476
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Study on the adverse effects of secondary antituberculous drugs, with special reference to mental disorders induced by cycloserine and ethionamide].
    Ono K; Hashigami Y; Itonaga K; Aida Y; Fujino S
    Iryo; 1969 Jan; 23(1):85-91. PubMed ID: 5783221
    [No Abstract]   [Full Text] [Related]  

  • 60. [On the administration of ethionamide-chlorhydrate in pulmonary tuberculosis and meningeal tuberculosis].
    Schrádi A; Bene J; Szabó A; Molnár E
    Z Tuberk Erkr Thoraxorg; 1968 Mar; 127(5):307-11. PubMed ID: 5755348
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.